[Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects]

E U Walther; E Dietrich; R Hohlfeld

[Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects]

Nervenarzt. 1996 Jun;67(6):452-6.

[Article in German]

Authors

E U Walther¹, E Dietrich, R Hohlfeld

Affiliation

¹ Neurologische Klinik und Poliklinik, Klinikum Grosshadern, München.

PMID: 8767199

Abstract

Interferon beta-1b has been shown to reduce the frequency and severity of exacerbations in relapsing-remitting multiple sclerosis (MS). Unrealistic expectations of the patient and unexpected side effects may lead to discontinuation of the drug. Here we provide guidelines how to inform the patient adequately before therapy and discuss the most common side effects of interferon therapy.

Publication types

English Abstract
Review

MeSH terms

Adjuvants, Immunologic / administration & dosage*
Adjuvants, Immunologic / adverse effects
Blood Cell Count
Female
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta / administration & dosage*
Interferon-beta / adverse effects
Liver Function Tests
Male
Multiple Sclerosis / therapy*
Neurologic Examination / drug effects
Patient Education as Topic*
Recombinant Proteins / administration & dosage
Recombinant Proteins / adverse effects

Substances

Adjuvants, Immunologic
Recombinant Proteins
Interferon beta-1b
Interferon-beta
Interferon beta-1a